DrugPatentWatch Database Preview
Rifamycin - Generic Drug Details
Try a free trialSee Plans and Pricing
What are the generic drug sources for rifamycin and what is the scope of rifamycin freedom to operate?
Rifamycin
is the generic ingredient in one branded drug marketed by Cosmo Technologies and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Rifamycin has twenty-five patent family members in eighteen countries.
There are eleven drug master file entries for rifamycin. One supplier is listed for this compound.
Summary for rifamycin
| International Patents: | 25 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 11 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 13 |
| Clinical Trials: | 25 |
| Patent Applications: | 581 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | rifamycin at DailyMed |
Synonyms for rifamycin
| (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate |
| (7S,11S,13S,17S,18S,12R,14R,15R,16R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7 ,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<4, 7>.0<5,28>]triaconta-1(28),2,4,9,19,21,25( |
| (pentahydroxy-methoxy-heptamethyl-dioxo-[?]yl) acetate |
| 14897-39-3 (unspecified hydrochloride salt) |
| 15105-92-7 |
| 15105-92-7 (mono-hydrochloride salt) |
| 2,7-(Epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, (2S,16S,17S,18R,19R,20R,21S,22R,23S)- |
| 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate |
| 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione,5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate |
| 29),26-octaen-13-yl acetate |
| 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2-H)-dione, 21-acetate |
| 6998-60-3 |
| 8248AH |
| AKOS024281286 |
| AKOS027460740 |
| BDBM50391000 |
| C12044 |
| C37H47NO12 |
| CB-01-11 |
| CHEBI:29673 |
| CHEMBL437765 |
| D02549 |
| D0FX2Q |
| DTXSID1032014 |
| DU69T8ZZPA |
| EINECS 230-273-3 |
| GTPL4570 |
| HJYYPODYNSCCOU-ODRIEIDWSA-N |
| LMPK05000005 |
| LS-2172 |
| NSC133100 |
| Rifacin |
| Rifamicina |
| Rifamicina [INN-Spanish] |
| Rifamicine SV |
| Rifamycin (oral controlled-release, gastrointestinal-specific) |
| Rifamycin (oral controlled-release, gastrointestinal-specific), Cosmo/Dr Falk/Santarus |
| Rifamycin (USAN/INN) |
| Rifamycin [INN:BAN:DCF] |
| Rifamycin [USAN:INN:BAN:DCF] |
| RIFAMYCIN SODIUM |
| Rifamycin SV |
| Rifamycin SV MMX |
| Rifamycin SV, an antibiotic produced by certain strains of Streptomyces mediterranei, or the same substance produced by any other means |
| Rifamycine |
| Rifamycine [INN-French] |
| Rifamycinum |
| Rifamycinum [INN-Latin] |
| Rifocin |
| Rifocyn |
| RIFOMYCIN |
| Rifomycin SV |
| SC-49540 |
| SCHEMBL151824 |
| SR-01000872597 |
| SR-01000872597-1 |
| ST044225 |
| Tuborin |
| UNII-DU69T8ZZPA |
| ZINC169633673 |
US Patents and Regulatory Information for rifamycin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cosmo Technologies | AEMCOLO | rifamycin | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Cosmo Technologies | AEMCOLO | rifamycin | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Cosmo Technologies | AEMCOLO | rifamycin | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Cosmo Technologies | AEMCOLO | rifamycin | TABLET, DELAYED RELEASE;ORAL | 210910-001 | Nov 16, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
